Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001221508-10-000016
Filing Date
2010-09-24
Accepted
2010-09-24 16:33:39
Documents
4
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K MOLECULAR PHARMACOLOGY (USA) LTD. YEAR ENDED JUNE 30, 2010 form10k_06302010.htm 10-K 689659
2 ex311_june302010.htm EX-31.2 7790
3 ex312_june302010.htm EX-31.1 7697
4 ex32_june302010.htm EX-32 3899
  Complete submission text file 0001221508-10-000016.txt   710789
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

EIN.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50156 | Film No.: 101089151
SIC: 2834 Pharmaceutical Preparations